NAFCILLIN SODIUM (NAFCILLIN SODIUM) — FDA Approval ANDA062844 (WATSON LABS INC)
NAFCILLIN SODIUM (NAFCILLIN SODIUM) — FDA Approval ANDA062844 (WATSON LABS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NAFCILLIN SODIUM; Active ingredients: NAFCILLIN SODIUM; Application number: ANDA062844.
| Brand name | NAFCILLIN SODIUM |
|---|---|
| Active ingredients | NAFCILLIN SODIUM |
| Application number | ANDA062844 |
| Sponsor | WATSON LABS INC |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 5 |
| First approval date | 19881026 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →